US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk
Published
US regulators have strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Full ArticlePublished
US regulators have strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Full Articlehttps://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..